Article
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
International journal of antimicrobial agents - 1 Aug 2018
Pfaller Michael A, Huband Michael D, Mendes Rodrigo E, Flamm Robert K, Castanheira Mariana
Abstract excerpt
The activity of meropenem/vaborbactam was evaluated against 11 559 Enterobacteriaceae isolates, including 330 carbapenem-resistant phenotypes (CRE) and carbapenemase genotypes collected worldwide during 2015. Antimicrobial susceptibility testing for meropenem/vaborbactam (inhibitor at 8 mg/L) and comparators was performed by the reference broth microdilution method. CRE isolates were screened for the presence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.